Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Frédérique Giraud"'
Autor:
Ifri, Pascal
Publikováno v:
The French Review, 2018 Oct 01. 92(1), 254-255.
Externí odkaz:
https://www.jstor.org/stable/44864573
Autor:
Pascal Ifri
Publikováno v:
The French Review. 92:254-255
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e68a1baae053a9ee897132380eb792c
https://doi.org/10.1353/tfr.2018.0141
https://doi.org/10.1353/tfr.2018.0141
Autor:
Robert Lethbridge
Publikováno v:
French Studies. 72:119-120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ce58ad6a8660829c8bec65d276e0948
https://doi.org/10.1093/fs/knx257
https://doi.org/10.1093/fs/knx257
Autor:
Samuel Coavoux, Frédérique Giraud
Publikováno v:
Cahiers de la Recherche sur l'Education et les Savoirs, Vol 7, Pp 133-157 (2020)
Is school a positive or a negative model for museums? This article analyses museum education programs oriented towards children in three museums, two traditional and one on-line museum of children art. Drawing on interviews and observations, it shows
Externí odkaz:
https://doaj.org/article/afd4f7a6a4d8475dbb1747d5fa4e38de
Autor:
Pascaline Boudou-Rouquette, Jennifer Arrondeau, Claire Gervais, Jean-Philippe Durand, Elizabeth Fabre, Sixtine De Percin, Clémentine Vaquin Villeminey, Anne-Catherine Piketty, Nathalie Rassy, Guillaume Ulmann, Diane Damotte, Audrey Mansuet-Lupo, Frédérique Giraud, Marco Alifano, Marie Wislez, Jérôme Alexandre, Anne Jouinot, François Goldwasser
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103630- (2021)
Background: Immune checkpoint inhibitors (ICI) are dramatically active in a minority of non-small cell lung cancer (NSCLC) patients. We studied here the relationship between patients's metabolism and outcome under ICI. Methods: Metastatic NSCLC patie
Externí odkaz:
https://doaj.org/article/c752ad522f9e41baab6f8929446462cf
Autor:
Benoit Blanchet, Julien Kirchgesner, Audrey Thomas-Schoemann, Jeanne Chapron, Audrey Bellesoeur, Anne Jouinot, Laure Hirsch, Frédérique Giraud, M. Wislez, Claire Gervais, François Goldwasser, Jérôme Alexandre, Pascaline Boudou-Rouquette, Jennifer Arrondeau
Publikováno v:
European Journal of Cancer. 124:170-177
Background The occurrence of severe, acute limiting toxicity in patients receiving anti–programmed cell death receptor-1 monoclonal antibodies, such as nivolumab, is largely unpredictable. Sarcopenia was found to be associated with anti-cytotoxic T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ec1fb5f616863fb7e7af2091f7eb8f5
https://doi.org/10.1016/j.ejca.2019.11.003
https://doi.org/10.1016/j.ejca.2019.11.003
